Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
SKYX Platforms reported record third-quarter revenue of $25.7 million, representing 7.4% year-over-year growth and its 11th consecutive quarter of growth. The company highlighted its recent merger with Deako, which expanded its builder channel pipeline to approximately 4 million units. Management noted a strong cash position of $21 million and believes it has sufficient capital to reach cash-flow positive status.
Nakamoto Inc. reported Q3 2026 net income of $85.5 million, driven primarily by a $110.4 million gain in the fair value of its digital asset holdings. The company reported total operating revenue of $(1.9) million due to derivative losses and highlighted the extension of its Kraken loan facility maturity to December 2027.
Term
Q3 2026
“We spent the third quarter building. We launched Bitcoin Magazine TV to add year-round sponsorship revenue, took UTXO into structured credit, and held Bitcoin Asia in Hong Kong. We also announced Intelligence 2027, our first event built around AI. i27 takes our events business behind The Bitcoin Conference into the intersection between AI, investment, enterprise adoption and policy.”
David Bailey, Chairman and Chief Executive Officer of Nakamoto
“Markets move in cycles, and we are building Nakamoto to perform through all of them, by extending our debt maturities and building operating businesses that earn revenue beyond our Bitcoin holdings. We are confident that these initiatives and our selective approach to deploying capital will help us drive sustainable earnings and long-term shareholder value.”
David Bailey, Chairman and Chief Executive Officer of Nakamoto
Enovix Corp reported revenue of $11.0 million for the fiscal quarter ended October 4, 2026, up from $8.0 million in the prior year period. The company reduced its quarterly loss from operations to $39.3 million compared to $47.0 million in 2025, while maintaining a strong liquidity position with $405.5 million in cash and short-term investments.
HawkEye 360, Inc. significantly strengthened its balance sheet in 2026, with cash and cash equivalents increasing to $494.9 million from $92.7 million at year-end 2025. The company transitioned from a stockholders' deficit to a total stockholders' equity of $805.3 million, primarily driven by the conversion of mezzanine equity and an increase in additional paid-in capital.
Gemini Space Station, Inc. reported a total asset decrease from $1.80 billion at year-end 2025 to $1.58 billion as of September 30, 2026, driven by declines in cash and crypto assets held. The company's accumulated deficit widened to $2.32 billion, reflecting ongoing net losses during the period.
Cartesian Growth Corporation IV is a blank check company that completed its IPO in June 2026, raising $275 million. As of September 30, 2026, the company reported a net income of $2.3 million for the quarter, primarily driven by interest earned on investments held in the Trust Account, and is currently seeking a target for a business combination.
GigCapital9 Corp. is a shell company that completed its initial public offering in January 2026, raising $253 million. For the nine months ended September 30, 2026, the company reported net income of $5.1 million, primarily driven by $6.1 million in interest and dividend income from marketable securities held in its Trust Account.
Nova Minerals Corp reported a net loss of $12.0 million for the quarter ended September 30, 2026, compared to a $6.4 million loss in the prior year, driven primarily by increased exploration and evaluation expenses. The company is transitioning its focus toward developing a pilot-scale antimony processing facility in Alaska, supported by a $43.4 million award from the U.S. Department of War.
Silence Therapeutics reported a net loss of $39.7 million for the nine months ended September 30, 2026, a significant improvement from the $76.8 million loss in the prior year period. The company strengthened its balance sheet through a major share issuance in the third quarter, bringing cash and cash equivalents to $247.7 million, which management believes will fund operations until at least 2028.
York Space Systems Inc. reported a significant increase in total current assets to $579.2 million as of September 30, 2026, driven by growth in cash and contract assets. The company is actively executing an M&A strategy, highlighting recent acquisitions of Orbion Space Technologies, Solestial Space Technology, and All.Space Holdings.
Ameresco $125M Debt Financing with Nuveen Energy Infrastructure Credit
Ameresco's indirect subsidiary, Ameresco Euro Holdco Limited, entered into a $125 million senior secured credit agreement with Nuveen Energy Infrastructure Credit, with an option to expand by an additional $100 million. The facility matures in November 2031 and is designed to fund solar, battery storage, and energy efficiency projects across the UK and Europe. The financing is structured with limited recourse to the parent company and does not impact its senior secured corporate leverage ratios.
Bolt Biotherapeutics reported a net loss of $19.5 million for the nine months ended September 30, 2026, a significant reduction from the $26.7 million loss in the prior year period. The company recently acquired Prana Therapies, Inc. to pivot its focus toward the INSPIRE platform for multispecific antibodies while completing Phase 1/2 trials for BDC-4182.
Moodys Debt Financing Update with U.S. Bank Trust Company, National Association
Moody’s Corporation closed a public offering of €500 million aggregate principal amount of 4.125% Senior Notes due 2033. The notes were issued under a Twentieth Supplemental Indenture and the company intends to use the proceeds for general corporate purposes, including the repayment of its 1.75% Senior Notes due 2027.
ImmuCell reported Q3 2026 financial results with revenue growing 46% to $8.0 million and net income of $953,000. The company highlighted broad-based growth across sales territories and announced the termination of its At-The-Market (ATM) offering program due to a strong cash position.
Term
Q3 2026
“ImmuCell had a strong quarter. The expanded commercial team is delivering solid revenue growth as we reach more customers with our value propositions. Increased commercial activity was supported by increased output from the manufacturing team. We are investing in capacity expansion and colostrum sourcing capabilities for future demand, and those efforts are projected to be completed on time and within budget.”
Olivier te Boekhorst, President and CEO
“Today we are reporting net income of $953,000 for the third quarter of 2026, a $1.1 million increase compared to the third quarter of 2025. Revenue grew 46.0% to $8.0 million in the third quarter of 2026 compared to the third quarter of 2025, a comparison aided in part by the absence of distributor restocking headwinds that had adversely affected the third quarter sales in 2025.”
Liftoff Mobile, Inc. filed its 10-Q for the period ending September 30, 2026, following its June 2026 IPO. The company is classified as an emerging growth company and non-accelerated filer, reporting 169,444,265 shares of common stock outstanding as of November 5, 2026.
Nektar Therapeutics is a clinical-stage biopharmaceutical company focused on developing rezpegaldesleukin (NKTR-358) for autoimmune diseases. The company reported a transition to a non-accelerated filer status and continues to incur substantial net losses while relying on collaboration agreements and capital markets for funding.
The Tennessee Valley Authority's 2026 10-K filing outlines its financial and operational structure, including new accounting standards and risk management activities. The document highlights significant environmental and regulatory matters, such as compliance with the 2015 CCR Rule and the Clean Air Act, alongside strategic initiatives like the Enterprise Transformation Program.
NeoVolta Inc. reported a significant revenue decline to $2.79 million for the quarter ended September 30, 2026, compared to $6.65 million in the prior year, resulting in a net loss of $7.73 million. The company significantly increased its cash position through a secured debt facility, ending the period with $25.97 million in cash and cash equivalents.
CV Sciences reported a net loss of $1.5 million for the nine months ended September 30, 2026, compared to a loss of $0.8 million in the prior year period, primarily driven by a decrease in product sales and non-cash losses on debt conversions. Despite the net loss, the company generated positive cash flow from operations of $0.18 million and recorded a $0.5 million gain from a legal settlement during the third quarter.
Karbon Capital Partners Corp. reported net income of $7.25 million for the nine months ended September 30, 2026, primarily driven by $9.42 million in interest earned on marketable securities held in trust. As a shell company, it has not yet generated operating revenue and is currently focused on identifying a target for a business combination.
MariMed Inc. reported revenue of $44.2 million for the third quarter of 2026, a 9% increase year-over-year, though it recorded a net loss of $3.5 million due to high income tax provisions and interest expenses. The company's balance sheet shows $10.4 million in cash and a total of 405,996,010 common shares outstanding as of November 10, 2026.
Smartbird, Inc. (formerly Allbirds, Inc.) has completed the sale of its historical footwear business and is transitioning to a new AI Infrastructure Business. The company is currently an emerging growth company and reported 9,540,103 shares of Class A common stock outstanding as of November 3, 2026.
Helen of Troy M&A Deal with Empower Brands Holdings Group, LLC
Helen of Troy's Board of Directors unanimously rejected an unsolicited, non-binding acquisition proposal from Empower Brands (owned by Spectrum Brands and Oaktree Capital Management) at $37.00 per share in cash. The Board determined the offer significantly undervalues the company's standalone strategic plan and growth prospects, noting that Empower Brands declined to sign a customary non-disclosure agreement to review detailed financial plans.
Grown Rogue International reported Q3 2026 revenue of $11.0 million, a 29% increase year-over-year, driven by strong growth in New Jersey and Oregon. The company reported a GAAP net loss of $8.9 million, primarily due to a $5.0 million loss related to a strategic shift in its Illinois market entry. Management reaffirmed its full-year 2026 revenue guidance of $38-$41 million and 2027 revenue guidance of $55-$63 million.
“For us, it always comes back to the people buying what we make. They're spending their hard-earned money and trusting us to deliver products worth coming back for. We take that responsibility seriously, and as we grow, so does our commitment to getting it consistently right. I'm incredibly proud of how our team has maintained that focus while bringing several new markets online simultaneously. We've welcomed talented new people who are working alongside our existing team, bringing fresh perspectives to our deep operational experience. This combination gives me tremendous confidence in our ability to execute on our ambitious growth plans.”
Intuitive Machines, Inc. filed its 10-Q for the period ending September 30, 2026, reporting 177,394,607 shares of Class A common stock outstanding as of November 5, 2026. The company is classified as a non-accelerated filer and an emerging growth company, highlighting risks related to its limited operating history, reliance on U.S. government contracts, and the technical challenges of lunar missions.
Southeast Airport Group Insider Anton Jose Antonio Perez Buys $498K of Stock
Anton Jose Antonio Perez bought 1,875 shares of Southeast Airport Group at $265.36 to $266.69 a share (average $265.41) in 2 transactions, worth $498K in total on Nov 9, 2026. Shares held after the trade: 1,875 (+4.2%).
Larimar Therapeutics Director Thomas Edward Hamilton Buys $187K of Stock
Thomas Edward Hamilton, Director, bought 70,000 shares of Larimar Therapeutics, Inc. at $2.67 a share, worth $187K in total on Nov 12, 2026. Shares held after the trade: 70,000.
Centuri Holdings Insider Carl C. Icahn Sells $30.1M of Stock
Carl C. Icahn sold 1,500,433 shares of Centuri Holdings, Inc. at $17.50 to $21.00 a share (average $20.09) in 4 transactions, worth $30.1M in total between Nov 9, 2026 and Nov 12, 2026. Shares held after the trade: 12,835,611 (-2.5%).
Pagaya Technologies CFO Jonathan Dobres Sells $174K of Stock
Jonathan Dobres, CFO, sold 10,217 shares of Pagaya Technologies Ltd. at $17.07 a share, worth $174K in total on Nov 10, 2026. Shares held after the trade: 0 (-100.0%).
South Plains Financial Insider Richard D. Campbell Sells $1.07M of Stock
Richard D. Campbell sold 24,754 shares of South Plains Financial, Inc. at $43.28 a share, worth $1.07M in total between Nov 9, 2026 and Nov 10, 2026. Shares held after the trade: 1,307,658 (-1.3%).